A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation.
Redecke V, Tawaratsumida K, Larragoite ET, Williams ESCP, Planelles V, Spivak AM, Hirayama L, Elgort M, Swenson S, Smith R, Worthen B, Zimmerman R, Slev P, Cahoon B, Astill M, Häcker H.
Redecke V, et al.
Sci Rep. 2021 Dec 30;11(1):24507. doi: 10.1038/s41598-021-04298-1.
Sci Rep. 2021.
PMID: 34969960
Free PMC article.